Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pasireotide LAR in Gonadotroph Adenomas
NCT00929669Phase 2Terminated
- Sponsor
- University of Pennsylvania
- Start
- Jun 2009
- Primary completion
- Nov 2011
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pasireotide LAR in gonadotroph adenoma, sponsored by University of Pennsylvania. Started Jun 2009; status: terminated.
02
Drugs
pasireotide LAR
03
Conditions
gonadotroph adenoma
Beyond the preview
Go deeper on NCT00929669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00929669.